Description
R3TA — 20 mg lyophilised triple-agonist peptide for in-vitro GLP-1/GIP/glucagon receptor studies. Research use only; not for human use.
R3TA — 20 mg lyophilised triple-agonist peptide for in-vitro GLP-1/GIP/glucagon receptor studies. Research use only; not for human use.
| Certificate Of Analysis | https://verify.janoshik.com/tests/136713-Sample_2_85EDG3RL7MEU |
|---|